These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12529995)

  • 1. Tumour cell uptake of lactosaminated and intact N-succinyl-chitosans and antitumour effects of conjugates with mitomycin C.
    Kato Y; Onishi H; Machida Y
    Anticancer Res; 2002; 22(5):2771-6. PubMed ID: 12529995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactosaminated and intact N-succinyl-chitosans as drug carriers in liver metastasis.
    Kato Y; Onishi H; Machida Y
    Int J Pharm; 2001 Sep; 226(1-2):93-106. PubMed ID: 11532574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of lactosaminated and intact N-succinylchitosan-mitomycin C conjugates against M5076 liver metastatic cancer.
    Kato Y; Onishi H; Machida Y
    J Pharm Pharmacol; 2002 Apr; 54(4):529-37. PubMed ID: 11999131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of adriamycin against a liver metastatic model by encapsulation in liposomes.
    Yachi K; Suzuki N; Tanaka N; Okada K; Mitsui I; Kawato Y; Komagata Y; Komiyama K; Kikuchi H
    Biopharm Drug Dispos; 1996 Nov; 17(8):699-715. PubMed ID: 8950048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of chitosan and its derivatives to cancer chemotherapy.
    Kato Y; Onishi H; Machida Y
    In Vivo; 2005; 19(1):301-10. PubMed ID: 15796190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-succinyl-chitosan as a drug carrier: water-insoluble and water-soluble conjugates.
    Kato Y; Onishi H; Machida Y
    Biomaterials; 2004 Feb; 25(5):907-15. PubMed ID: 14609679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic characteristics and antitumor activity of the N-succinyl-chitosan-mitomycin C conjugate and the carboxymethyl-chitin-mitomycin C conjugate.
    Song Y; Onishi H; Nagai T
    Biol Pharm Bull; 1993 Jan; 16(1):48-54. PubMed ID: 8369752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polybutylcyanoacrylate nanoparticles as a carrier for mitomycin C in rabbits bearing VX2-liver tumor.
    Xi-Xiao Y; Jan-Hai C; Shi-Ting L; Dan G; Xv-Xin Z
    Regul Toxicol Pharmacol; 2006 Dec; 46(3):211-7. PubMed ID: 17010489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo drug release and antitumor characteristics of water-soluble conjugates of mitomycin C with glycol-chitosan and N-succinyl-chitosan.
    Sato M; Onishi H; Takahara J; Machida Y; Nagai T
    Biol Pharm Bull; 1996 Sep; 19(9):1170-7. PubMed ID: 8889036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization.
    Yu JM; Li YJ; Qiu LY; Jin Y
    J Pharm Pharmacol; 2009 Jun; 61(6):713-9. PubMed ID: 19505361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of antitumor and toxic side effects of mitomycin C-estradiol conjugates.
    Ishiki N; Onishi H; Machida Y
    Int J Pharm; 2004 Jul; 279(1-2):81-93. PubMed ID: 15234797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravesical cationic nanoparticles of chitosan and polycaprolactone for the delivery of Mitomycin C to bladder tumors.
    Bilensoy E; Sarisozen C; Esendağli G; Doğan AL; Aktaş Y; Sen M; Mungan NA
    Int J Pharm; 2009 Apr; 371(1-2):170-6. PubMed ID: 19135514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymeric prodrugs of mitomycin C designed for tumour tropism and sustained activation.
    Seymour LW; Soyez H; De Marre A; Shoaibi MA; Schacht EH
    Anticancer Drug Des; 1996 Jul; 11(5):351-65. PubMed ID: 8765529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and drug release characteristics of the conjugates of mitomycin C with glycol-chitosan and N-succinyl-chitosan.
    Sato M; Onishi H; Kitano M; Machida Y; Nagai T
    Biol Pharm Bull; 1996 Feb; 19(2):241-5. PubMed ID: 8850315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic effects of geldanamycin and antitumor drugs.
    Liao ZY; Zhang SH; Zhen YS
    Yao Xue Xue Bao; 2001 Aug; 36(8):569-75. PubMed ID: 12579931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological fate of highly-succinylated N-succinyl-chitosan and antitumor characteristics of its water-soluble conjugate with mitomycin C at i.v. and i.p. administration into tumor-bearing mice.
    Kato Y; Onishi H; Machida Y
    Biol Pharm Bull; 2000 Dec; 23(12):1497-503. PubMed ID: 11145185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coupling of lactose molecules to the carrier protein hinders the spleen and bone marrow uptake of doxorubicin conjugated with human albumin.
    Di Stefano G; Fiume L; Baglioni M; Busi C; Chieco P; Kratz F; Mattioli A
    Eur J Pharm Sci; 2007 Feb; 30(2):136-42. PubMed ID: 17218086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of mitomycin C (MMC) after intraperitoneal administration of MMC-gelatin gel and its anti-tumor effects against sarcoma-180 bearing mice.
    Fujita T; Tamura T; Yamada H; Yamamoto A; Muranishi S
    J Drug Target; 1997; 4(5):289-96. PubMed ID: 9169985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intraperitoneal chemotherapy with mitomycin C bound to activated carbon nanoparticles for nude mice bearing human gastric carcinoma].
    Qu QL; Zhang YG; Yang LZ; Sun L
    Zhonghua Zhong Liu Za Zhi; 2006 Apr; 28(4):257-60. PubMed ID: 16875622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of antitumor activities of hyaluronate binding antitumor drugs: synthesis, characterization and antitumor activity.
    Akima K; Ito H; Iwata Y; Matsuo K; Watari N; Yanagi M; Hagi H; Oshima K; Yagita A; Atomi Y; Tatekawa I
    J Drug Target; 1996; 4(1):1-8. PubMed ID: 8798873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.